Literature DB >> 7603912

Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy.

M Theiss1, M P Wirth, A Manseck, H G Frohmüller.   

Abstract

One hundred thirty patients with an observed follow-up of more than 10 years after radical prostatectomy were restaged with regard to local extent of the tumor in relation to the prostate capsule. Of 112 patients with surgically staged negative pelvic lymph nodes, 62 had a tumor-free prostate capsule, 24 had capsular invasion without penetration, and 26 had tumors extending through the capsule of the prostate. Observed overall and disease-free 10-year-survival rates were 79% and 69.4%, respectively, in patients with absence of capsular involvement and 70.8% and 66.7%, respectively, in patients with capsular invasion alone. In patients with capsular penetration, however, the survival rates significantly decreased to 57.7% (P = 0.018) and to 38.5 (P = 0.017), respectively. The overall progression rate was found to be significantly higher in patients with tumors extending through the prostatic capsule (46.2%), as compared to those with absence of capsular involvement (21%; P = 0.014) as well as to those with capsular invasion alone without penetration (25%; P = 0.034). Thus, in contrast to capsular invasion alone, capsular penetration means a poor prognostic indicator, which accounts for a reduced survival expectancy and a higher progression rate following radical prostatectomy. Therefore, tumors with capsular invasion and those with capsular penetration should not be grouped together in the same tumor stage as done in the 1987 edition of the TNM tumor classification system.

Entities:  

Mesh:

Year:  1995        PMID: 7603912     DOI: 10.1002/pros.2990270104

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  11 in total

1.  Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy.

Authors:  Sıtkı Ün; Hakan Türk; Osman Koca; Rauf Taner Divrik; Ferruh Zorlu
Journal:  Turk J Urol       Date:  2015-06

Review 2.  Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.

Authors:  D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

3.  Development of targeted near-infrared imaging agents for prostate cancer.

Authors:  Xinning Wang; Steve S Huang; Warren D W Heston; Hong Guo; Bing-Cheng Wang; James P Basilion
Journal:  Mol Cancer Ther       Date:  2014-09-19       Impact factor: 6.261

4.  Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.

Authors:  R F Hoedemaeker; J B Rietbergen; R Kranse; T H van der Kwast; F H Schröder
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy.

Authors:  Katherine Fleshner; Melissa Assel; Nicole Benfante; Justin Lee; Andrew Vickers; Samson Fine; Sigrid Carlsson; James Eastham
Journal:  J Urol       Date:  2016-04-02       Impact factor: 7.450

6.  Prognostic factors for failure after prostatectomy.

Authors:  Gregory P Swanson; Joseph W Basler
Journal:  J Cancer       Date:  2010-12-07       Impact factor: 4.207

7.  Prognostic factors in prostate cancer.

Authors:  A Buhmeida; S Pyrhönen; M Laato; Y Collan
Journal:  Diagn Pathol       Date:  2006-04-03       Impact factor: 2.644

8.  Predictive factors for biochemical recurrence in radical prostatectomy patients.

Authors:  Hakan Turk; Orcun Celik; Sitki Un; Mehmet Yoldas; Cemal Selcuk İsoglu; Mustafa Karabicak; Batuhan Ergani; Gokhan Koc; Ferruh Zorlu; Yusuf Ozlem Ilbey
Journal:  Cent European J Urol       Date:  2015-11-30

9.  Primary cilia are lost in preinvasive and invasive prostate cancer.

Authors:  Nadia B Hassounah; Ray Nagle; Kathylynn Saboda; Denise J Roe; Bruce L Dalkin; Kimberly M McDermott
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.

Authors:  Clare Verrill; Lucia Cerundolo; Chad Mckee; Michael White; Christiana Kartsonaki; Eve Fryer; Emma Morris; Simon Brewster; Indrika Ratnayaka; Luke Marsden; Hans Lilja; Ruth Muschel; Xin Lu; Freddie Hamdy; Richard J Bryant
Journal:  Oncotarget       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.